EMMA LUTZ: Open Payments
NPI 1477263911 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 10 payments from 7 companies in 2025. Trend: 2023 $917 · 2024 $708 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 1 | $136 |
| Biogen, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $76 |
| Gilead Sciences, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $27 |
| Indivior Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VYEPTI, SPINRAZA, MAVYRET, QULIPTA, MOUNJARO, SUBLOCADE, Ozempic.
Industry payments across CA — which companies pay providers there.
